NUS (National Cohorts Office)

Cohort Directory

The NCO Cohort Directory aims to signpost users to population cohorts in Singapore to maximise the use and translation of these valuable Singapore resources. It provides a high-level overview of the cohort profile, type of data collected and cohort contact information.

The BALANCE study utilises novel smartphone-based approaches to comprehensively explore the digital determinants of health among university students in real-time. The study integrates online questionnaires administered through REDCap, passive smartphone sensing, and Ecological Momentary Assessments (EMAs) to capture real-time digital behaviors and related health indicators. Questionnaire data include demographics, health behaviors, personality traits, self-reported anthropometrics, and mental and cognitive health. Passive tracking collects smartphone engagement patterns, GPS-derived environmental data and pedometer data in real time for 10 days. Repeated EMAs assess momentary digital media use, health behaviors and cognitive performance. The study aims to examine how real-time digital media use is associated with cognitive health outcomes.

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline18 to 34
RecruitmentNUS via email (online)
Sample size at baseline914
Baseline collection periodMay 2025 to Feb 2026
Follow-up timepointsNA
Questionnaire dataMedical history, tobacco use; alcohol consumption dietary assessment; sleep behaviour; physical activity status; cognitive function; mental health; personality and life goals; digital media use; sexual health; ecological momentary assessment (EMA); smartphone-Integrated sensors: usage time, frequency, app metadata, step count, GPS data
Physical measurementsAnthropometrics
BiochemistryNA
BiospecimensNA
OmicsNA
ImagesNA

Principal Investigator(s) (Emails): Associate Professor Falk Mueller-Riemenschneider (falk.m-r@nus.edu.sg)

Primary contact(s) (Emails):

Website: –

Selected Research Outputs:

BREAst screening Tailored for HEr (BREATHE) is a pilot risk-based screening programme that aims to study the acceptability of risk stratification to aid women in their decision making to attend regular screening. Shifting the paradigm from an age-based risk screening, BREATHE integrates both genetic and non-genetic factors to predict one’s breast cancer risk. Participants who have consented to the study would be required to attend three sessions; recruitment, 1st follow-up session and final follow-up session. With the data and biospecimens donated, participants would receive a tailored breast cancer risk report at the 1st follow-up session. The final follow-up session is conducted to evaluate the changes in the screening behaviours of participants, and assess if risk-based screening has improved an individual’s willingness to screen regularly.

GenderFemale
EthnicityChinese, Malay, Indian, Others
Age range at baseline35 to 69
RecruitmentClinic setting such as polyclinics and hospitals
Sample size at baseline4,592
Baseline collection period2021 to 2023
Follow-up timepoints3 months after recruitment, 2 years after recruitment
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, physical activity status, women’s health, quality of life, type of diet, probiotics use, supplement use, durian consumption, biopsies and benign breast diseases, type of gynaecological history, family history of cancers (breast, ovarian and others), parity, use of contraceptives and hormone replacement treatment
Physical measurementsAnthropometrics
Biochemistry testsNA
BiospecimensBuccal swaps
OmicsPolygenic risk scores
ImagesMammograms

Principal Investigator(s) (Emails): Associate Professor Mikael Hartman (mikael_hartman@nuhs.edu.sg)

Primary contact(s) (Emails):

Website: https://blog.nus.edu.sg/breathe/

Selected Research Outputs: PMID: 35358246

Over the course of 2009 and 2010, Singaporean women were enrolled in GUSTO, from a point in early pregnancy. With the longitudinal cohort study being in its 14th year, mother-child dyads have been extensively phenotyped with continuous collection of data. As the GUSTO children journey through life, we are there every step of the way. The detailed observations and sampling on these mothers and children have been instrumental in discovering features more representative of the local and Asian population that can be used to improve the health and potential of our communities, with an earlier start.

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline0-16 years
RecruitmentHospital based (NUH and KKH)
Sample size at baseline1,468
Baseline collection period2009 to 2010
Follow-up timepoints19-21 week, 26-28 week, 32-34 week, Delivery (2009 – 2011), Day 1, Week 1, Week 3, Month 3, Month 6 (2010 – 2012), Month 9, Month 12, Month 15, Month 18 (2011 – 2013), Month 24, Month 36 (2012 – 2014), Year 4 (2013 – 2015), Year 4.5, Year 5 (2014 – 2016), Year 5.5, Year 6 (2015 – 2017), Year 6.5, Year 7 (2016 – 2018), Year 8 (2017 – 2019), Year 9 (2018 – 2020), Year 10 (2019 – 2021), Year 10.5, Year 11 (2021 – 2022), Year 12 (2021 – 2023), Year 13 (2022 – current), Year 14 (2023 – current)
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, women’s health, cognitive function, mental health, quality of life, visit https://gustodatavault.sg/catalogue/?collection=gusto for more
Physical measurementsAnthropometrics, blood pressure, heart rate, grip strength, eye examination, bone density
Biochemistry testsGlycaemic, lipids, liver function, renal function, full blood count, inflammation, bone metabolism, growth hormones, endocrinology, thyroid function, metabolic
BiospecimensWhole blood, plasma, serum, DNA, RNA, stool, saliva, buccal swaps, urine, visit  https://gustodatavault.sg/biobank/ for more
OmicsVisit https://gustodatavault.sg/omics/
ImagesUltrasound and digital scans

Principal Investigator(s) (Emails): Professor Chong Yap Seng (obgcys@nus.edu.sg) and Professor Johan Eriksson (obgjge@nus.edu.sg)

Primary contact(s) (Emails): Huang Lehui Ann (annhuang@nus.edu.sg) and Vicky Tay (medthkv@nus.edu.sg)

Website: www.gusto.sg

Selected Research Outputs: PMID: 23912809

Health@NUS 2020 is a prospective cohort study conducted by researchers at the National University of Singapore (NUS) in partnership with the Singapore Government’s Health Promotion Board (HPB). Health@NUS 2020 follows NUS students longitudinally over a 2-year period during university and transition to early working life. The study leverages on mHealth data collection methods, including a Fitbit smartwatch and the Health Insights SG (hiSG) mobile app, which collects health behaviours, health and well-being data continuously over the 2-year period. Online surveys were administered through REDCAP survey tool at baseline, 12- and 24-month follow-ups, covering key areas such as demographics, subjective health, lifestyle behaviours, personality traits, mental well-being, and objective health outcomes. Clinical measurements, including height, weight, and blood pressure, were collected onsite by a trained study team.

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline18 to 26
RecruitmentNUS (online)
Sample size at baseline776
Baseline collection period2020 to 2022
Follow-up timepoints2022 – 2024
Questionnaire dataMedical history, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, women’s health, mental health, sedentary behaviour, screen time, life goals, lifestyle factors, COVID-19 history (24-month follow-up only)
Physical measurementsAnthropometrics, blood pressure, heart rate
BiochemistryNA
BiospecimensNA
OmicsNA
ImagesNA
OthersDigital biomarkers (smartphones and wearables)

Principal Investigator(s) (Emails): Associate Professor Falk Mueller-Riemenschneider (falk.m-r@nus.edu.sg)

Primary contact(s) (Emails):

Website: https://blog.nus.edu.sg/sphpanda/research-projects/healthnus/

Selected Research Outputs: PMID: 39018103

The Health@NUS 2025 cohort study aims to understand the health of full-time NUS undergraduates and their transition over their university studies since their matriculation. The study includes yearly online surveys administered through the REDCap survey tool, covering key areas such as demographics, subjective health, lifestyle behaviors, personality traits, mental well-being, and objective health outcomes. Clinical measurements, including height, weight, and blood pressure, were collected onsite by a trained study team or during pre-matriculation medical examination.

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline18 to 39
RecruitmentNUS (online)
Sample size at baseline1, 119
Baseline collection period2025
Follow-up timepoints2026 – 2028
Questionnaire dataMedical history, vaping and tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, women’s health, mental health, sedentary behaviour, screen time, sexual health, lifestyle factors
Physical measurementsAnthropometrics, blood pressure, heart rate
BiochemistryNA
BiospecimensNA
OmicsNA
ImagesNA

Principal Investigator(s) (Emails): Associate Professor Falk Mueller-Riemenschneider (falk.m-r@nus.edu.sg)

Primary contact(s) (Emails):

Website:

Selected Research Outputs:

The Healthy Campus Initiative (HCI) cohort study aims to understand the health of full-time NUS undergraduates and their transition over their university studies since their matriculation in Semester 1, of Academic Year 2021-22. The study includes three online surveys administered through the REDCap survey tool, covering key areas such as demographics, subjective health, lifestyle behaviors, personality traits, life priorities, mental well-being, and objective health outcomes. Clinical measurements, including height, weight, and blood pressure, were collected onsite by a trained study team. Data collection is scheduled at three time points: Baseline (AY 2021-22, Semester 1), after around two years, and after four years.

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline17 to 41
RecruitmentNUS (online)
Sample size at baseline997
Baseline collection periodSeptember 2021 to February 2022
Follow-up timepointsJanuary 2024 – May 2024, January 2025 – May 2025
Questionnaire dataMedical history, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, women’s health, mental health, sedentary behaviour, screen time, sedentary behaviour, screen time, life goals, lifestyle factors, sexual health, COVID-19 history (not in baseline)
Physical measurementsAnthropometrics, blood pressure, heart rate
BiochemistryNA
BiospecimensNA
OmicsNA
ImagesNA

Principal Investigator(s) (Emails): Associate Professor Falk Mueller-Riemenschneider (falk.m-r@nus.edu.sg)

Primary contact(s) (Emails):

Website: https://blog.nus.edu.sg/sphpanda/

Selected Research Outputs: PMID: 39095795

The Health for Life in Singapore (HELIOS) Study is a prospective cohort study, which aims to identify the genetic and environmental factors that underpin development of obesity, diabetes, cardiovascular disease and other complex diseases in Singapore. The ultimate goal is to use the knowledge generated to develop new approaches for prediction, prevention, early detection and better treatment of these chronic diseases, thereby promoting healthy aging and well-being in Singapore.

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline30 to 84
RecruitmentPopulation based (through publicity materials and activities)
Sample size at baseline50,000
Baseline collection period2017 to 2025
Follow-up timepointsTBC
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, men’s health, women’s health, cognitive function, mental health, quality of life, family history
Physical measurementsAnthropometrics, blood pressure, heart rate, grip strength, eye examination, bone density, spirometry, treadmill
Biochemistry TestsGlycaemic, lipids, liver function, renal function, full blood count, inflammation, bone metabolism, endocrinology
BiospecimensWhole blood, plasma, stool (only a subset of participants), saliva (only a subset of participants), urine, skin tapes
OmicsGWAS, WGS, WGBS, metabolomics, proteomics
ImagesUltrasound, DEX, retinal images

Principal Investigator(s) (Emails): Professor John Chambers (john.chambers@ntu.edu.sg)

Primary contact(s) (Emails): Professor John Chambers (john.chambers@ntu.edu.sg)

Website: https://www.healthforlife.sg/

Selected Research Outputs: PMID: 41469377

The Integrated Women Health Programme (IWHP) was initiated to identify and address in a comprehensive fashion, the health care needs of mid-life Singaporean women, particularly in relation to bone mineral density, muscle, and adiposity. The study recruited women aged 45 to 69 attending well-woman clinics at the National University Hospital Singapore. We also plan to explore novel correlates of important health issues related to midlife women through the use of objectively-measured and novel technologies such as D3-creatine using LC-MS/MS technology, serum biomarkers, and a 6-minute magnetic resonance imaging of the whole body using AMRA Medical technologies.

GenderFemale
EthnicityChinese, Malay, Indian, Others
Age range at baseline45 to 69
RecruitmentHospital based (NUH)
Sample size at baseline1, 201
Baseline collection period2014 to 2016
Follow-up timepoints2021 – 2024
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, sleep behaviour, physical activity status (only at baseline), women’s health, cognitive function (only at follow-up), mental health, reproductive information, menopausal and urinary symptoms, sexual health, visual functioning questionnaire (only at follow-up), life-space restriction (only at follow-up)
Physical measurementsAnthropometrics, blood pressure, heart rate, grip strength, bone density, physical performance battery (repeated chair stands, gait speeds, balance tests), cardiac measurements to measure subclinical atherosclerosis and arterial health (only at follow-up) (pulse-wave analysis, cardio-ankle vascular index, carotid intima-media thickness, advanced glycation end-products, ankle brachial index)
Biochemistry testsGlycaemic (fasting glucose, insulin), lipids (LDL, HDL, triglycerides), renal function (creatinine, cystatin c), inflammation (IL-6, TNF-α, hsCRP) (only at baseline), bone metabolism (vitamin D), endocrinology (estradiol), D3-creatine muscle mass measurements, APOE4 genotyping, pTau-181, pTau-217 (only at follow-up)
BiospecimensSerum, DNA, urine
OmicsNA
ImagesCarotid ultrasound, DXA, MRI of muscle and fat composition (liver fat, muscle fat infiltration) using AMRA Medical technology, DXA body composition (fat and lean mass)

Principal Investigator(s) (Emails): Professor Yong Eu Leong (obgyel@nus.edu.sg)

Primary contact(s) (Emails):

Website: https://medicine.nus.edu.sg/obgyn/research/reproductive-development-biology-research-program/iwhp.html/

Selected Research Outputs: PMID: 29415269

Repository of healthy volunteers, patients with cardiometabolic and cardiomyopathies. Stored samples include serum and whole blood. All individuals have cardiovascular magnetic resonance imaging.

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline21 to 99
RecruitmentHospital or clinic setting
Sample size at baseline3, 000 (on-going)
Baseline collection period2015 to current
Follow-up timepointsNA
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, sleep behaviour, physical activity status
Physical measurementsAnthropometrics, blood pressure, heart rate, eye examination
Biochemistry testsNA
BiospecimensWhole blood, serum, DNA
OmicsNA
ImagesCardiac MRI

Principal Investigator(s) (Emails): Associate Professor Calvin Chin (gmsccwl@gms.edu.sg)

Primary contact(s) (Emails): –

Website:

Selected Research Outputs:

PHASE is a nationally representative longitudinal survey of older community-dwelling Singapore citizens and permanent residents aged 60 years and above at baseline, with three waves of data –  Wave 1 in 2009 (n=4,990); Wave 2 in 2011-2012 (n=3,103; follow-up of Wave 1 participants); Waves 3 2015 (n=1,572; follow-up of Wave 2 participants).

GenderMale, Female
EthnicityChinese, Malay, Indian, Other
Age range at baseline60 to 101
RecruitmentPopulation-based (through national database)
Sample size at baseline4, 990
Baseline collection period2009 (Wave 1)
Follow-up timepoints2011 to 2012 (Wave 2), 2015 (Wave 3)
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, sleep behaviour, quality of life, healthcare access, health literacy, income adequacy, physical function and health status, productive activities, psychosocial measures, social environment, utilisation and preventive care
Physical measurementsAnthropometrics, blood pressure, heart rate, physical performance (chair stand test, hand grip strength, gait speed)
Biochemistry testsNA
BiospecimensNA
OmicsNA
ImagesNA

Principal Investigator(s) (Emails): Associate Professor Rahul Malhotra (rahul.malhotra@duke-nus.edu.sg)

Primary contact(s) (Emails): care-datarequest@duke-nus.edu.sg

Website: www.duke-nus.edu.sg/care/research/dataset-codebook

Selected Research Outputs: PMID: 31377801; 30165421; 29190378

PIONEER is a nationally-representative and a population-based study investigating the clinical, biological, anthropomorphic, and psychosocial phenotypes of elderly (≥ 60 years) Singaporeans (Malays, Indians and Chinese) to better understand the epidemiology, burden, and complex mechanisms associated with age-related sensory deterioration.

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline60 and above
RecruitmentPopulation-based (through national database)
Sample size at baseline2, 643
Baseline collection period2017 to 2022
Follow-up timepointsOct 2022 to current
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, cognitive function, mental health, quality of life, falls, independence, frailty, economic burden, caregiver burden, proxy questionnaire on behalf of the participants
Physical measurementsAnthropometrics, blood pressure, heart rate, grip strength, eye examination, bone density, gait/ balance, hearing, smell
Biochemistry testsGlycaemic, lipids, liver function, renal function, full blood count, inflammation, bone metabolism, serum creatinine, serum albumin, blood typing, calcium, vitamin D
BiospecimensPlasma, DNA, RNA, urine
OmicsNA
ImagesRetinal images, OCT, OCT-A

Principal Investigator(s) (Emails): Prof Ecosse Lamoureux (ecosse.lamoureux@duke-nus.edu.sg) and Dr Preeti Gupta (preeti.gupta@duke-nus.edu.com.sg)

Primary contact(s) (Emails): –

Website:

Selected Research Outputs: PMID: 33269099

SG100K is a multi-institutional cohort study in Singapore which aims to recruit 100,000 diverse Chinese, Malay, and Indian participants to identify the social, environmental, lifestyle, and genetic factors associated with diseases prevalent in Singapore. SG100K comprises participants from four cohort studies in Singapore: Health for Life in Singapore (NTU), Singapore Population Health Studies (NUS), Singapore Epidemiology of Eye Diseases (SERI) and SingHeart (NHCS). The study will collect detailed information on health, lifestyle, environment, and physical well-being from 100,000 volunteers. This includes assessment of diet and lifestyle choices through a structured questionnaire, and measurement of waist-hip circumference, blood pressure, physical fitness, lung function, body composition, skeletal health, cardiovascular health, cognitive performance, as well as glucose and cholesterol levels. Key biological samples such as blood, urine and skin tapes are also collected.

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline21 to 84
RecruitmentPopulation-based (through publicity materials)
Sample size at baseline100, 000 (expected)
Baseline collection period2004 to current
Follow-up timepointsNA
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, men’s health, women’s health, cognitive function, mental health, quality of life
Physical measurementsAnthropometrics, blood pressure, heart rate, grip strength, eye examination, bone density, fitness test with ECG monitoring, accelerometer, spirometry, arterial stiffness, skin physiology, audiometry
Biochemistry testsGlycaemic, lipids, renal function, full blood count
BiospecimensWhole blood, urine
OmicsWhole genome sequencing, DNA methylation profiling
ImagesCarotid ultrasound, DXA, 2D colour fundus, OCT-A

Principal Investigator(s) (Emails): Professor John Chambers (john.chambers@ntu.edu.sg)

Primary contact(s) (Emails): –

Website:

Selected Research Outputs: PMID: 31626772; 34960161; 35361824

Initiated in 1993, the main objective of Singapore Chinese Health Study (SCHS) is to build a stable cohort for long term study of dietary, genetic, and environmental determinants of cancer and other chronic diseases in Singapore. The cohort included Chinese Singaporeans residing in public housing. One of the major strengths of SCHS is its ability to examine potential disease-protective dietary factors that are rarely consumed among the well-studied occidental populations.

GenderMale, Female
EthnicityChinese
Age range at baseline45 to 74 years
RecruitmentPopulation-based (through invitation letters)
Sample size at baseline63, 257
Baseline collection period1993 to 1998
Follow-up timepoints1999 to 2004, 2006 to 2010, 2014 to 2017, 2017 to 2018, 2018 to 2019
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, women’s health, cognitive function
Physical measurementsAnthropometrics, blood pressure, grip strength, time-up-and-go, gait speed
Biochemistry testsNA
BiospecimensPlasma, serum, buffy coat, urine
OmicsNA
ImagesNA

Principal Investigator(s) (Emails): Professor Koh Woon Puay (kohwp@nus.edu.sg)

Primary contact(s) (Emails): –

Website: https://www.schs.pitt.edu/

Selected Research Outputs: PMID: 28535164; 29457582; 30165478

The Singapore Cohort Of Risk factors for Myopia (SCORM), the first myopia cohort study launched in Asia and one of the first studies in the world, launched in the year 1999. It has provided rich information on the aetiology, pathological abnormalities, genetic and environmental risk factors for myopia in Singapore children. The SCORM study included a total of 1,979 children aged 7 to 9 years to determine the environmental and genetic risk factors for myopia, ocular biometric changes and pathological abnormalities. The SCORM Children were recruited from three schools in Singapore during the years 1999 and 2001 and were followed up annually until 2006 (1,053 children).

GenderMale, Female
EthnicityChinese, Malay, Indian, Other
Age range at baseline7 to 9 years
RecruitmentSingapore schools
Sample size at baseline1, 979
Baseline collection period1999 to 2001
Follow-up timepoints2002, 2003, 2004, 2005, 2006, 2007, 2016, 2017, 2019
Questionnaire dataMedical history, dietary assessment, sleep behaviour, physical activity status, women’s health, cognitive function, mental health, quality of life, reading, outdoor activities, near work, family medical history, parental near work, parental smoking, Raven matrix
Physical measurementsAnthropometrics, eye examination, hearing
Biochemistry testsNA
BiospecimensDNA, saliva, buccal swaps
OmicsNA
ImagesFundus photos, OCT

Principal Investigator(s) (Emails): Professor Saw Seang Mei (sphssm@nus.edu.sg)

Primary contact(s) (Emails): –

Website: –

Selected Research Outputs: PMID: 11211020

The Singapore Epidemiology of Eye Diseases (SEED) study aimed to investigate prevalence, incidence, risk factors and impact of Asian eye diseases in the three major racial/ethnic groups (Chinese, Malays, Indians) in Singapore. It used an age-stratified random sample selected from 15 districts approximating Singapore’s socio-economic and demographic structure. SEED has three further follow-ups: 6-year follow-up (SEED-2), 12-year follow-up (SEED-3) and 20-year follow-up (SEED-4). The detailed phenotyping conducted by SEED highlights ethnic differences in disease prevalence and risk factors, which provides important insights into global eye health.

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline40 to 80 years
RecruitmentPopulation-based (southern-western part of Singapore)
Sample size at baseline10, 033
Baseline collection period2004 to 2011
Follow-up timepoints2011 to 2017, 2017 to current
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, women’s health, cognitive function, mental health, quality of life, demographics, family history of diseases, diabetes awareness.
Physical measurementsAnthropometrics, blood pressure, heart rate, eye examination
Biochemistry testsGlycaemic, lipids, renal function, full blood count
BiospecimensWhole blood, urine, buccal swab
OmicsGenotyping array, metabolite
ImagesRetinal photography, cirrus OCT (macula), spectralis OCT, angiovue OCT-A, triton OCT-A

Principal Investigator(s) (Emails): Professor Cheng Ching-Yu (chingyu.cheng@duke-nus.edu.sg)

Primary contact(s) (Emails): 

Website: https://blog.nus.edu.sg/seed/

Selected Research Outputs: PMID: 33393587; 30529130; 25104651

The Singapore Life Panel (SLP) was launched in 2015 under the stewardship of the Centre for Research on the Economics of Ageing (CREA) and followed more than 12,000 Singaporeans aged 50–70 at baseline (July 2015) for a period of five years. Across 60 completed monthly waves, the average number of responses per wave remained stable at approximately 7,500, resulting in nearly 500,000 completed interviews. During the CREA period, the SLP captured detailed self-reported indicators of individuals’ economic well-being, supplemented by more limited measures from other domains of well-being. Surveys were administered primarily through an online survey portal, supported by operational efforts to sustain participation. The SLP has continued beyond its initial five-year period under the Centre for Research on Successful Ageing (ROSA) from 2021 onward, featuring a refreshed design and an expanded focus on holistic well-being. However, the current release includes only the first five years of SLP data collected under CREA.

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline50 to 70
RecruitmentPopulation-based (through national household sampling frame)
Sample size at baseline14, 400
Baseline collection period2015
Follow-up timepointsMonthly
Questionnaire dataMedical history, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, men’s health, women’s health, cognitive function, mental health, quality of life
Physical measurementsAnthropometrics
Biochemistry testsNA
BiospecimensNA
OmicsNA
ImagesNA

Principal Investigator(s) (Emails): Professor Paulin Straughan (paulints@smu.edu.sg)

Primary contact(s) (Emails): rosa@smu.edu.sg

Website: https://rosa.smu.edu.sg/singapore-life-panel/about-singapore-life-panelr

Selected Research Outputs: PMID: 37073729, 38603917, https://doi.org/10.1142/S0217590818420043  

The primary objective of SLAS-YS was to furnish scientific evidence to support policy development and implementation of strategies, programs, and practices related to disability prevention and the promotion of healthy ageing in Singapore. The Singapore Longitudinal Ageing Studies (SLAS) comprised of two cohorts aged 55 and above: SLAS-1 (commenced in 2003) and SLAS-2 (commenced in 2008). The Yishun Study (YS) recruited 542 adults (≥21 years) from Yishun via stratified random sampling. Additional recruitment of older individuals (>75 years) occurred at senior activity centres.

SLAS-1

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline55 to 98 years
RecruitmentCommunity based (south-east region)
Sample size at baseline2, 804
Baseline collection period2003 to 2005
Follow-up timepoints2005 to 2007, 2007 to 2009, 2018 to 2020
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, physical activity status, cognitive function, mental health, quality of life
Physical measurementsAnthropometrics, blood pressure, heart rate, eye examination, ECG monitoring, spirometry, POMA-B, POMA-G
Biochemistry TestsGlycaemic, lipids, liver function, renal function, full blood count, inflammation, bone metabolism, metabolic, Vitamin B12, folate, Apo-E-genotype
BiospecimensWhole blood
OmicsNA
ImagesMRI

SLAS-2

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline54 to 94 years
RecruitmentCommunity based (south-east region)
Sample size at baseline3, 270
Baseline collection period2008 to 2013
Follow-up timepoints2013 to 2018
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, cognitive function, mental health, quality of life, frequency of computer and internet usage, mobile phone usage, history of eye health, levels of tiredness, activities of daily living, severity of dyspnoea
Physical measurementsAnthropometrics, blood pressure, heart rate, grip strength, eye examination, ECG monitoring, accelerometer, spirometry, POMA-B, POMA-G, functional reach, fast gait speed, dynamometry
Biochemistry TestsGlycaemic, lipids, liver function, renal function, full blood count, inflammation, bone metabolism, thyroid function, metabolic, APOE, folate, TNFA
BiospecimensWhole blood
OmicsNA
ImagesMRI

Principal Investigator(s) (Emails) for SLAS 1 and 2:  Professor Roger Ho Chun Man (pcmrhcm@nus.edu.sg)

Primary contact(s) (Emails) for SLAS 1 and 2:

Website for SLAS 1 and 2: 

Selected Research Outputs for SLAS: PMID: 33589714

YS

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline21 to 90 years
RecruitmentCommunity based (yishun)
Sample size at baseline534
Baseline collection period2017 to 2019
Follow-up timepointsNA
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, physical activity status, women’s health
Physical measurementsAnthropometrics, blood pressure, grip strength, eye examination, bone density, fat and muscle mass measurement, gait parameters, physiological profile assessment
Biochemistry TestsNA
BiospecimensWhole blood
OmicsNA
ImagesNA

Principal Investigator(s) (Emails): Dr Rachel Cheong Chin Yee (cheong.chin.yee@ktph.com.sg)

Primary contact(s) (Emails):

Website:

Selected Research Outputs: PMID: 33589714

The Singapore Longitudinal Early Development Study (SG-LEADS) seeks to understand factors that can enhance or hinder Singaporean children’s early childhood development with an aim to inform public policies that can help each child reach his or her potential. SG-LEADS is a nationally representative household survey that focuses on Singaporean households with children aged 0–6 at the baseline. It adopts a multi-stage probability sampling — clustered and stratified sampling strategy — with an oversample of the low-income households residing in 1–3-room HDB (Housing Development Board) public housing units. In-home face-to-face interviews were conducted on the computer-assisted personal interviewing (CAPI) systems. The baseline survey was conducted between 2018 and 2019. Up to two eligible children and their primary caregivers were interviewed in each household. In total, 5,005 Singaporean children aged 0–6 in 3,476 households and their primary caregivers were successfully interviewed. In 2021, 4,351 children in 3,017 households were successfully re-interviewed. Wave 3 data collection is conducted in 2025.

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline0 to 6 and their primary caregivers
RecruitmentPopulation-based
Sample size at baseline5, 005
Baseline collection period2018 to 2019
Follow-up timepoints2021, 2025
Questionnaire dataTobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, women’s health, cognitive function, mental health, social-emotional well-being and health of children, family relations, socioeconomic and demographic characteristics
Physical measurementsNA
Biochemistry testsNA
BiospecimensNA
OmicsNA
ImagesMRI

Principal Investigator(s) (Emails): Professor Wei-Jun Jean Yeung (yeungwjj@sics.a-star.edu.sg)

Primary contact(s) (Emails):

Website: https://sg-leads.org/

Selected Research Outputs: PMID: 38419773

Over the course of 2015 and 2017, Singaporean women without fertility issues and intending to get pregnant were enrolled in S-PRESTO. S-PRESTO has the advantage to prospectively assess a wide array of potential determinants of future health outcomes in women from preconception to post-delivery and in their offspring across the earliest development from embryonic stages into early childhood.

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline0 to 8
RecruitmentHospital based (NUH and KKH)
Sample size at baseline1, 054
Baseline collection period2015 to 2017
Follow-up timepointsPreconception Visit 1 (2015 – 2017), Preconception Visit 2 (2015 – 2018), Pregnancy Visit 1 (2015 – 2019), Pregnancy Visit 2, Pregnancy Visit 3 (2015 – 2019), Pregnancy Visit 4, Pregnancy Visit 5, Delivery (2015 – 2019), Partner Visit (2015 – 2021), Week 1 (2016 – 2019), Week 3, Month 1, Week 6, Month 3 (2016 – 2020), Month 6, Month 12, Month 18 (2017 – 2021), Month 24 (2018 – 2021), Month 36 (2019 – 2022), Year 4 (2020 – 2023), Year 5 (2021 – current), Year 6 (2022 – current), Year 7 (2023 – current), Year 8 (2024 – current)
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, men’s health, women’s health, mental health, quality of life, visit https://gustodatavault.sg/catalogue/?collection=spresto for more
Physical measurementsAnthropometrics, blood pressure, grip strength, bone density
Biochemistry testsGlycaemic, lipids, liver function, renal function, full blood count, inflammation, growth hormones, metabolic
BiospecimensWhole blood, plasma, serum, DNA, RNA, stool, saliva, buccal swaps, urine, hair, epithelial swabs, breastmilk, skin microbiome, nasal swab
OmicsAvailable, visit https://gustodatavault.sg/biobank/biodata?collection=spresto
ImagesUltrasound, digital scans

Principal Investigator(s) (Emails): Professor Chong Yap Seng (obgcys@nus.edu.sg) and Professor Johan Eriksson (obgjge@nus.edu.sg)

Primary contact(s) (Emails): Huang Lehui Ann (annhuang@nus.edu.sg) and Vicky Tay (medthkv@nus.edu.sg)

Website: www.gusto.sg

Selected Research Outputs: PMID: 33222050

The Singapore Population Health Studies (SPHS) is a population-based health research initiative that aims to (i) investigate the interactions between lifestyle, physiological, genetic and other omics biomarkers and their impact on health and longevity; (ii) serve as a platform to monitor risk factors in the population and gain insight into determinants of health-related behaviours; and (iii) understand disease aetiology in urban Asian settings, and the development of improved preventive and therapeutic measures for Singapore and other Asian populations. Over a span of 20 years, health, lifestyle, environment, and physical well-being from over 70,000 volunteers across a collection of seven independent cohorts, including (i) three independent phases of the Multi-Ethnic Cohort (MEC1, MEC2 and MEC3), (ii) Diabetic Cohort (DC), (iii) Singapore Health Studies (SH2012, SH2) and (iv) Community Healthy Study (CHS).

GenderMale, Female
EthnicityChinese, Malay, Indian
Age range at baseline21 to 84
RecruitmentPopulation-based
Sample size at baselineUp to 70, 000
Baseline collection period2004 to current
Follow-up timepoints2011 – 2016, 2016 – 2020, 2022 – 2026
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, men’s health, women’s health, cognitive function, mental health, quality of life
Physical measurementsAnthropometrics, blood pressure, heart rate, grip strength, eye examination, bone density, accelerometer, spirometry, skeletal
Biochemistry testsGlycaemic, lipids, lung function, renal function, liver function
BiospecimensBuffy coat, plasma, serum, whole blood, urine
OmicsWhole genome sequencing with National Precision Medicine Programme
ImagesCarotid ultrasound, DXA, retinal images

Principal Investigator(s) (Emails): Associate Professor Sim Xueling (ephsx@nus.edu.sg)

Primary contact(s) (Emails): SSHSPHDataRequest@nus.edu.sg

Website: https://blog.nus.edu.sg/sphs/

Selected Research Outputs: PMID: 29452397; 32474429; 25884916; 29544448; 34360408; 34476210

SingHeart proposes to study a prospective cohort of relatively healthy individuals, using comprehensive clinical information, advanced imaging (including cardiac MRI and CT calcium score), cardiovascular exercise physiology, metabolomics, circulating markers of cardiac injury, genetic analysis stool microbiome and non-mydriatic retinal imaging. These findings will be correlated with adverse clinical outcomes including death, stroke and myocardial infarction. In selected cases, follow-up imaging and biomarker samples will also be obtained. These studies will enable us to begin to address a critical gap in our knowledge as to how best to interpret the very large number of cardiovascular tests done in Singapore and how to better predict outcomes and manage healthcare costs in our local populations.

GenderMale, Female
EthnicityChinese, Malay, Indian, Other
Age range at baseline21 to 69
RecruitmentPublic or clinic setting (e.g. polyclinics)
Sample size at baseline1, 162 (on-going)
Baseline collection period2015 to current
Follow-up timepointsAt 10 years and 20 years following participant recruitment
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, men’s health, mental health, quality of life, family history, TCM, supplement use, tea/ coffee consumption
Physical measurementsAnthropometrics, blood pressure, heart rate
Biochemistry testsGlycaemic, lipids, liver function, renal function, full blood count
BiospecimensWhole blood, serum, DNA
OmicsWhole genome sequencing, metabolomic
ImagesVascular ultrasound, retinal imaging, cardiac MRI and CT calcium score

Principal Investigator(s) (Emails): Professor Yeo Khung Keong (yeo.khung.keong@singhealth.com.sg)

Primary contact(s) (Emails): –

Website:

Selected Research Outputs: PMID: 31752689

The Singapore Translational Cancer Consortium (STCC) Cancer Data Commons is a national infrastructure comprising of all oncology patients seen in Public Healthcare Institutions, amalgamated through linkages to clinical, specimen, research data (institutions / LCG / research programmes) and as well as other data types and is made available for research via data sharing on national platforms such as STCC Research Warehouse, Integrated Research Datahub and TRUST.


STCC

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline1 Month to 99 Years
RecruitmentNA
Sample size at baseline102, 303
Baseline collection period2010 to current
Follow-up timepointsNA
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, men’s health, women’s health, cognitive function, mental health, quality of life
Physical measurementsAnthroprometric, blood pressure, heart rate, grip strength, eye examinations, bone density, fitness test with ECG
Biochemistry testsGlycemic, lipids, liver function, renal function, full blood count, inflammation, bone metabolism, growth hormones, autoimmune, endocrinology, thyroid function, cardiac, hepatitis, metabolic, oncology, sepsis
BiospecimensTissue repository and pathology archival specimen, whole blood, plasma, serum, DNA, RNA, stool, saliva, buccal swabs, urine, fresh frozen tissue (normal and tumour), FFPE tissue
OmicsNA
ImagesUltrasound, X-ray, digital scans from various radiology department

Principal Investigator(s) (Emails): Professor Chng Wee Joo (weejoo.chng@nus.edu.sg) and Professor Iain Tan Bee Huat (iain.tan.b.h@singhealth.com.sg)

Primary contact(s) (Emails): catalogue.administrator@stcc.cris.sg

Website: https://www.stcc.sg/

Selected Research Outputs:

 

Singapore Lymphoma Study (SLS)

The Singapore Lymphoma Study (SLS) aims to comprehensively characterize the molecular landscape of lymphoma, with a particular focus on subtypes that occur at higher frequencies in Asian populations. Through this in-depth evaluation, the study seeks to identify and develop novel biomarkers, diagnostic assays, and therapeutic targets, as well as to inform new treatment strategies, especially for lymphoma subtypes that are unique or more prevalent among Asians.

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline13 to 97 years
RecruitmentClinic setting
Sample size at baseline2, 959 (6, 000 target)
Baseline collection period2004 to current
Follow-up timepointsNA
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, sleep behaviour, physical activity status, men’s health, women’s health
Physical measurementsAnthropometric, blood pressure, heart rate
Biochemistry testsLiver function, renal function, full blood count, inflammation, thyroid function, hepatitis, oncology
BiospecimensWhole blood, plasma, serum, DNA, RNA, buccal swab, fresh frozen tissues tumour tissue from biopsy, formalin-fixed paraffin-embedded tissues, PBMC, BMA, CSF
OmicsSequencing data (NGS, WGS)
ImagesNA

Principal Investigator(s) (Emails): Professor Lim Soon Thye (lim.soon.thye@singhealth.com.sg)

Primary contact(s) (Emails): catalogue.administrator@stcc.cris.sg

Website: https://www.nccs.com.sg/research-innovation/our-researchers/dmo-researchers/dmo-research-signature-programmes

Selected Research Outputs: PMID: 37032358; 35021606; 35075133

 

Colo-SCRIPT 

Colo-SCRIPT (Colorectal cancer subtype-specific research informs phenotypes, diagnostics and treatments) is a national colorectal cancer program that performs multi-modal molecular characterisation of colorectal neoplasms (CRNs) and colorectal cancers (CRC) with the objective to understand subtype-specific biology in the course of oncogenesis and cancer progression to enable the development of tailored strategies for subtype-specific prevention, detection, diagnosis and treatment. 

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline21 to 91 Years
RecruitmentClinic setting
Sample size at baseline1, 731 (2, 000 target)
Baseline collection period2024 to 2039
Follow-up timepointsNA
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, physical activity status
Physical measurementsAnthropometric
Biochemistry testsNA
BiospecimensFresh frozen tissues and formalin-fixed paraffin-embedded tissues
OmicsBulk whole genome sequencing, whole exome sequencing, RNA, xenium
ImagesNA

Principal Investigator(s) (Emails): Professor Iain Tan Bee Huat (iain.tan.b.h@singhealth.com.sg)

Primary contact(s) (Emails): catalogue.administrator@stcc.cris.sg

Website: –

Selected Research Outputs: PMID: 40187357; 39725547; 40299767

 

CaLiBRe

CaLiBRe (Cancer Liquid Biopsies for Real-time diagnostics and early intervention) is an end-to-end national cancer liquid biopsy program that seeks to use multi-modal profiling of liquid biopsies and data analytics to transform cancer care.

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline21 to 91 Years
RecruitmentClinic setting
Sample size at baseline7, 334 (9, 000 target)
Baseline collection period2019 to 2034
Follow-up timepointsNA
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, physical activity status
Physical measurementsAnthropometric
Biochemistry testsNA
BiospecimensPlasma, PBMC, buffy Coat
OmicsTargeted genome sequencing, whole exome sequencing
ImagesNA

Principal Investigator(s) (Emails): Professor Iain Tan Bee Huat (iain.tan.b.h@singhealth.com.sg)

Primary contact(s) (Emails): catalogue.administrator@stcc.cris.sg

Website: https://www.a-star.edu.sg/gis/our-science/precision-medicine-and-population-genomics/calibre

Selected Research Outputs: PMID: 39216476; 37713482; 40664638

 

TETRAD 

Recognising the need for a nationwide registry, members of the Singapore Leukemia Workgroup initiated the development of a unified Acute Myeloid Leukemia (AML) clinical database. This registry incorporates standardized data fields and harmonised database definitions to be adopted across participating centres, enabling consistent and comprehensive data collection. The database currently comprises clinical data from more than 1,500 AML patients treated at Singapore General Hospital, the National University Cancer Institute Singapore, and Tan Tock Seng Hospital.

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline15 to 92 Years
RecruitmentClinic setting
Sample size at baseline1, 391
Baseline collection period2005 to current
Follow-up timepointsOn diagnosis and 1st relapse
Questionnaire dataMedical history, medication use, tobacco use, alcohol consumption, dietary assessment, sleep behaviour, physical activity status, men’s health, women’s health, cognitive function, mental health, quality of life
Physical measurementsAnthropometric, blood pressure, heart rate, grip strength, eye examinations, bone density, fitness test with ECG
Biochemistry testsGlycemic, lipids, liver function, renal function, full blood count, inflammation, bone metabolism, growth hormones, autoimmune, endocrinology, thyroid function, cardiac, hepatitis, metabolic, oncology, sepsis
BiospecimensPlasma, DNA, lysate, frozen mononuclear cells
OmicsNA
ImagesUltrasound, X-ray and digital scans

Principal Investigator(s) (Emails): Associate Professor Charles Chuah (charles.chuah.t.h@singhealth.com.sg) and Associate Professor Linn Yeh Ching (linn.yeh.ching@singhealth.com.sg)

Primary contact(s) (Emails): catalogue.administrator@stcc.cris.sg

Website:

Selected Research Outputs: PMID: 36709073; 38820078; 34904798

THE SIGNS Study is a nationally-representative, longitudinal survey of community-dwelling older Singapore residents (i.e., citizens and permanent residents), aged 60 years and above at baseline. It collects comprehensive data, through survey questionnaires and physical measurements on the status of and change over time in the health and wellbeing of older Singapore residents. To date, four waves of THE SIGNS Study have been completed or planned: Wave 1 in 2016-2017 (n=4,549); Wave 2 in 2019 (n=2,887; follow-up of Wave 1 participants); Waves 3a and 3b in 2023-2025 (n=6,841; comprising Wave 3a (n=1,535; follow-up of Wave 2 participants) and Wave 3b (n=5,306; enrolment of new participants to refresh and replenish the cohort, to account for ageing and attrition, and serving as a second baseline); and Wave 4 in 2027 (expected n=4,500; follow-up of Waves 3a and 3b participants).

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline60 to 106 (Wave 1), and 60 to 102 (Wave 3b)
RecruitmentPopulation-based (national database)
Sample size at baseline4, 549 (Wave 1), and 5, 306 (Wave 3b)
Baseline collection period2016 to 2017 (Wave 1), and 2024 to 2025 (Wave 3b)
Follow-up timepoints2019, 2023 to 2024, 2027
Questionnaire dataMedical history, medication use, tobacco use, sleep behaviour, physical activity status, women’s health, cognitive function, mental health, quality of life, digital technology use for general and health purposes, healthcare access, income adequacy, physical function and health status, productive activities, psychosocial measures, social environment, utilisation and preventive care
Physical measurementsAnthropometrics, blood pressure, heart rate, physical performance (balance, chair stand test, hand grip strength, gait speed)
Biochemistry testsNA
BiospecimensNA
OmicsNA
ImagesNA

Principal Investigator(s) (Emails): Associate Professor Rahul Malhotra (rahul.malhotra@duke-nus.edu.sg) and Associate Professor Angelique Chan (angelique.chan@duke-nus.edu.sg)

Primary contact(s) (Emails): care-datarequest@duke-nus.edu.sg

Website: https://www.duke-nus.edu.sg/care/research/the-signs-study

Selected Research Outputs: PMID: 32744310; 38364320; 36626304

UTOPIA cohort comprises more than 7000 individuals, including those with cancer or elevated cancer risk and healthy individuals. Eligible participants may have known or suspected genetic mutations, atypical cellular changes (e.g., polyps), or previously diagnosed gene variants linked to cancer. Participants include adults and children recruited across several hospitals including the National Cancer Centre Singapore (NCCS), KK Women’s and Children’s Hospital (KKH), Changi General Hospital (CGH), Singapore General Hospital (SGH), and Tan Tock Seng Hospital (TTSH). Data collected encompasses detailed medical and family histories, genetic information, proteomics, histopathology, biochemical labs, treatment records, and biospecimens (including blood, saliva, buccal swabs, urine, tissue biopsies, and other bodily fluids).

GenderMale, Female
EthnicityChinese, Malay, Indian, Others
Age range at baseline0 and above
RecruitmentClinic setting
Sample size at baseline5, 129 (20, 000 target)
Baseline collection period2012 to current
Follow-up timepointsNA
Questionnaire dataMedical history, women’s health, family history, histopathology, clinical genetic testing results
Physical measurementsNA
Biochemistry testsNA
BiospecimensWhole blood, plasma, DNA, RNA, fresh frozen tissues, formalin-fixed paraffin-embedded tissues, tissue derived cell line
OmicsGenetic sequencing, functional studies
ImagesX-ray

Principal Investigator(s) (Emails): Associate Professor Joanne Ngeow (joanne.ngeow@ntu.edu.sg)

Primary contact(s) (Emails): Caitlin Nicole Samy Victoria (caitlin.nicole.s.v@nccs.com.sg)

Website: –

Selected Research Outputs: PMID: 40138602, 36562461, 37046302